Lung cancer mortality statistics

Deaths

Deaths from lung cancer, 2017-2019, UK

 

Proportion of all deaths

Percentage lung cancer contributes to total cancer deaths, 2017-2019, UK

 

Age

Peak rate of lung cancer deaths, 2017-2019, UK

 

Trend over time

Lung cancer mortality rates have changed differently for each sex since the early 1970s, UK

Lung cancer is the most common cause of cancer death in the UK, accounting for 21% of all cancer deaths (2017-2019).[1-4]

In females in the UK, lung cancer is the most common cause of cancer death (21% of all female cancer deaths). In males in the UK, it is the most common cause of cancer death (21% of all male cancer deaths).

46% of lung cancer deaths in the UK are in females, and 54% are in males (2017-2019).

Lung cancer mortality rates (European age-standardised Open a glossary item (AS) rates) in the UK are significantly lower in females than in males (2017-2019).

Lung cancer mortality rates (European age-standardised Open a glossary item (AS) rates) for persons are significantly higher than the UK average in Scotland, Wales and Northern Ireland, and significantly lower than the UK average in England.

For lung cancer, mortality differences between countries largely reflect differences in incidence.

Lung Cancer (C33-C34), Annual Average Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Persons Population, UK, 2017-2019

  England Scotland Wales Northern Ireland UK
Female Deaths 12,749 2,028 883 480 16,140
Crude Rate 45.0 72.7 55.5 50.2 48.0
AS Rate 44.6 69.2 49.5 54.4 47.3
AS Rate - 95% LCL 44.2 67.5 47.6 51.6 46.9
AS Rate - 95% UCL 45.1 71.0 51.3 57.2 47.7
Male Deaths 15,047 2,020 1,014 550 18,631
Crude Rate 54.4 76.2 65.6 59.4 56.8
AS Rate 63.6 86.3 67.7 77.0 66.0
AS Rate - 95% LCL 63.0 84.1 65.3 73.3 65.5
AS Rate - 95% UCL 64.2 88.5 70.1 80.7 66.6
Persons Deaths 27,795 4,048 1,898 1,030 34,771
Crude Rate 49.7 74.4 60.5 54.7 52.3
AS Rate 53.0 76.4 57.4 63.8 55.5
AS Rate - 95% LCL 52.6 75.0 55.9 61.5 55.1
AS Rate - 95% UCL 53.3 77.7 58.9 66.0 55.8
95% LCL and 95% UCL are the 95% lower and upper confidence limits around the AS Rate Open a glossary item

See also

Lung cancer incidence statistics by sex and UK region

Lung cancer survival statistics

Cancer mortality statistics for common cancers in the UK

References

  1. England and Wales data were accessed from Nomis mortality statistics by underlying cause, sex and age, November 2021: Nomis mortality statistics by underlying cause, sex and age.
  2. Scotland data were provided by ISD Scotland on request, November 2021. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp(link is external).
  3. Northern Ireland data were provided by the Northern Ireland Cancer Registry on request, February 2022. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
  4. Population data were published by the Office for National statistics, accessed July 2020. The data can be found here: Population estimates for the UK, England and Wales, Scotland and Northern Ireland, provisional: mid-2019.

About this data

Data is for UK, 2017-2019, C33-C34.

Last reviewed:

Lung cancer mortality is strongly related to age, with the highest mortality rates being in older people. In the UK in 2017-2019, on average each year half of deaths (50%) were in people aged 75 and over.[1-4] This largely reflects higher incidence and lower survival for lung cancer in older people.

Age-specific mortality rates rise steeply from around age 55-59. The highest rates are in the 85 to 89 age group for females and the 90+ age group for males. Mortality rates are significantly lower in females than males in a number of (mainly older) age groups. The gap is widest at age 90+, when the age-specific mortality rate is 1.9 times lower in females than males.

Lung Cancer (C33-C34), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Persons Population, UK, 2017-2019

See also

Lung cancer incidence statistics by age

Lung cancer survival statistics

Cancer mortality statistics by age for all cancers

References

  1. England and Wales data were accessed from Nomis mortality statistics by underlying cause, sex and age, November 2021: Nomis mortality statistics by underlying cause, sex and age.
  2. Scotland data were provided by ISD Scotland on request, November 2021. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp(link is external).
  3. Northern Ireland data were provided by the Northern Ireland Cancer Registry on request, February 2022. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
  4. Population data were published by the Office for National statistics, accessed July 2020. The data can be found here: Population estimates for the UK, England and Wales, Scotland and Northern Ireland, provisional: mid-2019.

About this data

Data is for UK, 2017-2019, ICD-10 C33-C34.

Last reviewed:

Lung cancer European age-standardised (AS) Open a glossary item mortality rates for females and males combined decreased by 31% in the UK between 1971-1973 and 2017-2019.[1-4] The change varied markedly between sexes.

For females, lung cancer AS mortality rates in the UK increased by 77% between 1971-1973 and 2017-2019. For males, lung cancer AS mortality rates in the UK decreased by 59% between 1971-1973 and 2017-2019.

Over the last decade in the UK (between 2007-2009 and 2017-2019), lung cancer AS mortality rates for females and males combined decreased by 16%. In females AS mortality rates decreased by 8%, and in males rates decreased by 24%.

Lung Cancer (C33-C34), European Age-Standardised Mortality Rates per 100,000 Persons Population, UK, 1971-2019

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Lung cancer mortality rates have varied between age groups in females in the UK since the early 1970s.[1-4] Rates in 0-24s have remained stable, in 25-49s have decreased by 58%, in 50-59s have decreased by 32%, in 60-69s have increased by 39%, in 70-79s have increased by 143% and in 80+s have increased by 254%.

Lung Cancer (C33-C34), European Age-Standardised Mortality Rates per 100,000 Female Population, By Age, UK, 1971-2019

Lung cancer mortality rates have decreased overall in all broad age groups in males in the UK since the early 1970s.[1-4] Rates in 0-24s have decreased by 78% (though the absolute change is very small as rates are overall low in this age group), in 25-49s have decreased by 81%, in 50-59s have decreased by 79%, in 60-69s have decreased by 72%, in 70-79s have decreased by 60% and in 80+s have decreased by 5%.

Lung Cancer (C33-C34), European Age-Standardised Mortality Rates per 100,000 Male Population, By Age, UK, 1971-2019

Lung cancer mortality trends by age between 1950 and 1970 show the early stages of the patterns seen in the data from 1971 onwards: rates peaked and then started to fall in the youngest age groups first, with each subsequent age group then peaking and falling one after the other. [5-7] This reflects trends by age in smoking prevalence, and as reliable cancer incidence data are not available pre-1970s so mortality data from the 1950s and 1960s is important evidence of the association between cigarette smoking trends and lung cancer trends. The drop in general population smoking rates over time is driven by never-smokers not starting smoking, rather than current smokers quitting; younger age groups had their peak smoking rates earlier in the 20th century and have since been increasingly less likely to smoke, while older age groups started smoking at a young age and never gave up, so their smoking rates began to fall only when smokers began to die.

Lung Cancer (C33-C34) European Age-Standardised Mortality Rates and Smoking Prevalence, Great Britain, 1948-2019

See also

Lung cancer incidence trends over time

Lung cancer survival trends over time

Lung cancer risk factors

References

  1. England and Wales data were accessed from Nomis mortality statistics by underlying cause, sex and age, November 2021: Nomis mortality statistics by underlying cause, sex and age.
  2. Scotland data were provided by ISD Scotland on request, November 2021. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp(link is external).
  3. Northern Ireland data were provided by the Northern Ireland Cancer Registry on request, February 2022. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
  4. Population data were published by the Office for National statistics, accessed July 2020. The data can be found here: Population estimates for the UK, England and Wales, Scotland and Northern Ireland, provisional: mid-2019.

  5. Swerdlow AJ, dos Santos Silva I, and Doll R. Cancer Incidence and Mortality in England Wales: trends and risk factors. 2001: Oxford University Press.

  6. Doll R and Hill AB. Smoking and carcinoma of the lung. Preliminary report. British Medical Journal 1950:739-48.

  7. Quinn M, Babb P, Brock A et al. Cancer Trends in England Wales 1950-1999. Vol. SMPS No. 66. 2001: TSO.

  8. Sex specific smoking prevalence in Great Britain 1948-1970. PN Lee Statistics and Computing Ltd. International Smoking Statistics Web Edition (http://www.pnlee.co.uk/iss2.htm)

  9. Adult smoking habits in Great Britain: 1974-2020 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/drugusealcoholandsmoking/datasets/adultsmokinghabitsingreatbritain

     

About this data

Data is for UK, 1971-2019, C33-C34.

Cancers in children and young people (aged 0-24) are best classified using a different system to cancers in adults, so the figures presented here may not correspond with those elsewhere.

Last reviewed:

It is projected that the average number of deaths from lung cancer in the UK every year will rise from around 36,800 deaths in 2023-2025 to around 41,500 deaths in 2038-2040.[1]

Lung cancer mortality rates are projected to fall by 9% in the UK between 2023-2025 and 2038-2040, to 48 deaths per 100,000 people on average each year by 2038-2040.[1] This includes a similar decrease for males and females.

For females, lung cancer European age standardised (AS) Open a glossary item mortality rates in the UK are projected to fall by 6% between 2023-2025 and 2038-2040, to 45 deaths per 100,000 per year by 2038-2040.[1] For males, AS rates are projected to fall by 12% between 2023-2025 and 2038-2040, to 52 deaths per 100,000 per year by 2038-2040.[1]

Lung cancer (C33-C34), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1975-2040

Download the data (xlsx)

See also

Find out how these projections were calculated

Mortality trends over time for lung cancer

Projections of mortality for all cancers combined

Download the projections data table

References

Calculated by the Cancer Intelligence Team at Cancer Research UK, February 2023. Age-period-cohort modelling approach described here, using 2020-based population projections (Office for National Statistics) and observed cancer mortality data (1975-2018).

About this data

Projections are based on mortality data from 1975-2018 (England, Scotland, Wales and Northern Ireland); the above figure presents all UK data from 1975-2018 (observed) and 2019-2040 (projected). Number of deaths and age-standardised rates are presented as annual averages for each 3-year rolling period. ICD-10 codes C33-C34.

Projections are based on observed mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is evidence for a strong association between lung cancer mortality and deprivation for both males and females in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are 170% higher for males living in the most deprived areas compared with the least deprived, and 176% higher for females.[1]

Lung Cancer (C33-C44), European Age-Standardised Mortality Rates by Deprivation Quintile, England, 2007-2011

The estimated deprivation gradient in lung cancer mortality between people living in the most and least deprived areas in England has not changed in the period 2002-2011. It has been estimated that there would have been around 9,900 fewer lung cancer deaths each year in England during 2007-2011 if all people experienced the same mortality rates as the least deprived.[1]

See also

Find out more about the counting and coding of this data

Deprivation gradient for cancer mortality

Deprivation gradient in lung cancer incidence

Socio-economic variation in cancer mortality for Scotland

Socio-economic variation in cancer mortality for Wales

Socio-economic variation in cancer mortality for Northern Ireland

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England:  Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 (C33-C44)

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

An estimated 668,000 lung cancer deaths have been avoided in the UK by 2021 because mortality rates dropped from their peak levels in the 1970s for males and 2000s for females [1-4].

This includes more than 653,000 male deaths avoided since the male mortality rate peaked in 1979, and around 14,300 female deaths avoided since the female mortality rate peaked in 2008.

Lung Cancer (C33-C44), Observed Deaths, and Expected Deaths if Mortality Rates Had Not Fallen from Peak, UK, 1971-2021

Download this data

See also

Lung cancer incidence statistics by sex and UK region

Lung cancer survival statistics

Cancer mortality statistics for common cancers in the UK

References

  1. Calculated by the Cancer Intelligence Team at Cancer Research UK, 2024, based on method set out in Siegel R, Ward E, Brawley O, Jemal A., Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. 

About this data

Data is for UK, 1971-2021, ICD-10 C33-C34.

The number of avoided lung cancer deaths is estimated by comparing the actual number of lung cancer deaths observed, with the number of lung cancer deaths expected if mortality rates had not fallen from their overall peak. The number of lung cancer deaths expected is calculated by subtracting the number of observed lung cancer deaths from the number of expected lung cancer deaths. Expected lung cancer deaths is calculated by applying age- and sex-specific lung cancer mortality rates from the year in which age- and nation-specific lung cancer age-standardised mortality rates peaked, to corresponding population figures.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Cancer stats explained

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate Online 

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 3.2 out of 5 based on 102 votes
Thank you!
We've recently made some changes to the site, tell us what you think